Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-proteinexpression" lymphoma with MYC and BCL2 rearrangements.

Uchida A, Isobe Y, Asano J, Uemura Y, Hoshikawa M, Takagi M, Miura I.

Haematologica. 2019 Jul;104(7):1417-1421. doi: 10.3324/haematol.2018.204958. Epub 2018 Dec 6.

2.

Master protocol trials in oncology: Review and new trial designs.

Hirakawa A, Asano J, Sato H, Teramukai S.

Contemp Clin Trials Commun. 2018 Aug 24;12:1-8. doi: 10.1016/j.conctc.2018.08.009. eCollection 2018 Dec.

3.

Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.

Uemura Y, Isobe Y, Uchida A, Asano J, Nishio Y, Sakai H, Hoshikawa M, Takagi M, Nakamura N, Miura I.

Cancer Sci. 2018 Apr;109(4):1254-1262. doi: 10.1111/cas.13512. Epub 2018 Feb 15.

4.

Flexible fate commitment of E2-2high common DC progenitors implies tuning in tissue microenvironments.

Onai N, Asano J, Kurosaki R, Kuroda S, Ohteki T.

Int Immunol. 2017 Dec 18;29(10):443-456. doi: 10.1093/intimm/dxx058.

PMID:
29106601
5.

Clinical features of IgG4-related periaortitis/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study.

Ozawa M, Fujinaga Y, Asano J, Nakamura A, Watanabe T, Ito T, Muraki T, Hamano H, Kawa S.

Arthritis Res Ther. 2017 Oct 4;19(1):223. doi: 10.1186/s13075-017-1432-8.

6.

Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1a receptor expression.

Ohata K, Kamijo-Ikemori A, Sugaya T, Hibi C, Nakamura T, Murase T, Oikawa T, Hoshino S, Katayama K, Asano J, Kimura K, Shibagaki Y.

Eur J Pharmacol. 2017 Nov 15;815:88-97. doi: 10.1016/j.ejphar.2017.09.005. Epub 2017 Sep 6.

PMID:
28888756
7.

Intrinsic Autophagy Is Required for the Maintenance of Intestinal Stem Cells and for Irradiation-Induced Intestinal Regeneration.

Asano J, Sato T, Ichinose S, Kajita M, Onai N, Shimizu S, Ohteki T.

Cell Rep. 2017 Aug 1;20(5):1050-1060. doi: 10.1016/j.celrep.2017.07.019.

8.

Assessing the prediction accuracy of a cure model for censored survival data with long-term survivors: Application to breast cancer data.

Asano J, Hirakawa A.

J Biopharm Stat. 2017;27(6):918-932. doi: 10.1080/10543406.2017.1293082. Epub 2017 Mar 21.

PMID:
28324665
9.

Autoimmune Pancreatitis Can Transform Into Chronic Features Similar to Advanced Chronic Pancreatitis With Functional Insufficiency Following Severe Calcification.

Kanai K, Maruyama M, Kameko F, Kawasaki K, Asano J, Oguchi T, Watanabe T, Ito T, Muraki T, Hamano H, Matsumoto A, Arakura N, Kawa S.

Pancreas. 2016 Sep;45(8):1189-95. doi: 10.1097/MPA.0000000000000598.

PMID:
27400257
10.

Association Between Immunoglobulin G4-related Disease and Malignancy within 12 Years after Diagnosis: An Analysis after Longterm Followup.

Asano J, Watanabe T, Oguchi T, Kanai K, Maruyama M, Ito T, Muraki T, Hamano H, Arakura N, Matsumoto A, Kawa S.

J Rheumatol. 2015 Nov;42(11):2135-42. doi: 10.3899/jrheum.150436. Epub 2015 Oct 15.

PMID:
26472416
11.

[112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Recent Progress in IgG4-related Disease: Autoimmune Pancreatitis・IgG4-related Sclerosing Cholangitis].

Kawa S, Hamano H, Ito T, Watanabe T, Maruyama M, Kanai K, Oguchi T, Asano J, Muraki T, Arakura N.

Nihon Naika Gakkai Zasshi. 2015 Sep;104(9):1832-7. Japanese. No abstract available.

PMID:
30160880
12.

Extracorporeal shock wave lithotripsy treatment of pancreatic stones complicated with advanced stage autoimmune pancreatitis.

Maruyama M, Watanabe T, Kanai K, Oguchi T, Asano J, Ito T, Muraki T, Hamano H, Arakura N, Uehara T, Kawa S.

BMC Gastroenterol. 2015 Mar 10;15:28. doi: 10.1186/s12876-015-0255-9.

13.

Exposure of drugs for hypertension, diabetes, and autoimmune disease during pregnancy and perinatal outcomes: an investigation of the regulator in Japan.

Sato R, Ikuma M, Takagi K, Yamagishi Y, Asano J, Matsunaga Y, Watanabe H.

Medicine (Baltimore). 2015 Jan;94(1):e386. doi: 10.1097/MD.0000000000000386.

14.

The genetic association study between polymorphisms in uncoupling protein 2 and uncoupling protein 3 and metabolic data in dogs.

Udagawa C, Tada N, Asano J, Ishioka K, Ochiai K, Bonkobara M, Tsuchida S, Omi T.

BMC Res Notes. 2014 Dec 11;7:904. doi: 10.1186/1756-0500-7-904.

15.

Transient vascularization of transplanted human adult-derived progenitors promotes self-organizing cartilage.

Takebe T, Kobayashi S, Suzuki H, Mizuno M, Chang YM, Yoshizawa E, Kimura M, Hori A, Asano J, Maegawa J, Taniguchi H.

J Clin Invest. 2014 Oct;124(10):4325-34. doi: 10.1172/JCI76443. Epub 2014 Sep 9.

16.

Assessing the prediction accuracy of cure in the Cox proportional hazards cure model: an application to breast cancer data.

Asano J, Hirakawa A, Hamada C.

Pharm Stat. 2014 Nov-Dec;13(6):357-63. doi: 10.1002/pst.1630. Epub 2014 Jul 16.

PMID:
25044997
17.

Autoimmune pancreatitis can develop into chronic pancreatitis.

Maruyama M, Watanabe T, Kanai K, Oguchi T, Asano J, Ito T, Ozaki Y, Muraki T, Hamano H, Arakura N, Kawa S.

Orphanet J Rare Dis. 2014 May 21;9:77. doi: 10.1186/1750-1172-9-77.

18.
19.

Use of Cox's Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete Response.

Asano J, Hirakawa A, Hamada C, Yonemori K, Hirata T, Shimizu C, Tamura K, Fujiwara Y.

Int J Breast Cancer. 2013;2013:354579. doi: 10.1155/2013/354579. Epub 2013 Dec 5.

20.

Fulminant type 1 diabetes with robust recovery of insulin secretion: a case report.

Yamashita K, Sato Y, Seki K, Asano J, Funase Y, Yamauchi K, Aizawa T.

Diabetes Res Clin Pract. 2013 May;100(2):e34-8. doi: 10.1016/j.diabres.2013.01.032. Epub 2013 Feb 19.

PMID:
23433539
21.

Molybdophyllysin, a toxic metalloendopeptidase from the tropical toadstool, Chlorophyllum molybdites.

Yamada M, Tokumitsu N, Saikawa Y, Nakata M, Asano J, Miyairi K, Okuno T, Konno K, Hashimoto K.

Bioorg Med Chem. 2012 Nov 15;20(22):6583-8. doi: 10.1016/j.bmc.2012.09.036. Epub 2012 Sep 25.

PMID:
23063519
22.

Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer.

Griffith M, Mwenifumbo JC, Cheung PY, Paul JE, Pugh TJ, Tang MJ, Chittaranjan S, Morin RD, Asano JK, Ally AA, Miao L, Lee A, Chan SY, Taylor G, Severson T, Hou YC, Griffith OL, Cheng GS, Novik K, Moore R, Luk M, Owen D, Brown CJ, Morin GB, Gill S, Tai IT, Marra MA.

Pharmacogenomics J. 2013 Apr;13(2):148-58. doi: 10.1038/tpj.2011.65. Epub 2012 Jan 17.

PMID:
22249354
23.

The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.

Asano J, Nakano A, Oda A, Amou H, Hiasa M, Takeuchi K, Miki H, Nakamura S, Harada T, Fujii S, Kagawa K, Endo I, Yata K, Sakai A, Ozaki S, Matsumoto T, Abe M.

Leukemia. 2011 Jul;25(7):1182-8. doi: 10.1038/leu.2011.60. Epub 2011 Apr 8.

PMID:
21475253
24.

Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction.

Tezuka H, Abe Y, Asano J, Sato T, Liu J, Iwata M, Ohteki T.

Immunity. 2011 Feb 25;34(2):247-57. doi: 10.1016/j.immuni.2011.02.002. Epub 2011 Feb 17.

25.

Alternative expression analysis by RNA sequencing.

Griffith M, Griffith OL, Mwenifumbo J, Goya R, Morrissy AS, Morin RD, Corbett R, Tang MJ, Hou YC, Pugh TJ, Robertson G, Chittaranjan S, Ally A, Asano JK, Chan SY, Li HI, McDonald H, Teague K, Zhao Y, Zeng T, Delaney A, Hirst M, Morin GB, Jones SJ, Tai IT, Marra MA.

Nat Methods. 2010 Oct;7(10):843-7. doi: 10.1038/nmeth.1503. Epub 2010 Sep 12.

PMID:
20835245
26.

Digital gene expression by tag sequencing on the illumina genome analyzer.

Morrissy S, Zhao Y, Delaney A, Asano J, Dhalla N, Li I, McDonald H, Pandoh P, Prabhu AL, Tam A, Hirst M, Marra M.

Curr Protoc Hum Genet. 2010 Apr;Chapter 11:Unit 11.11.1-36. doi: 10.1002/0471142905.hg1111s65.

PMID:
20373513
27.

Evaluation of the clinical cutoff level of serum (1 --> 3)-beta-D-glucan in patients with connective tissue diseases complicated by deep fungal infections.

Kato K, Onoda S, Asano J, Fukaya S, Yoshida S.

Mod Rheumatol. 2010 Aug;20(4):366-9. doi: 10.1007/s10165-010-0287-5. Epub 2010 Mar 27.

PMID:
20349101
28.

Histone acetylation and steroid receptor coactivator expression during clofibrate-induced rat hepatocarcinogenesis.

Asano J, Kudo T, Shimizu T, Fan Y, Nanashima N, Yamana D, Miura T, Yamada T, Tsuchida S.

Cancer Sci. 2010 Apr;101(4):869-75. doi: 10.1111/j.1349-7006.2009.01460.x. Epub 2009 Dec 8.

29.

Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo.

Asano J, Tada H, Onai N, Sato T, Horie Y, Fujimoto Y, Fukase K, Suzuki A, Mak TW, Ohteki T.

J Immunol. 2010 Jan 15;184(2):736-45. doi: 10.4049/jimmunol.0900726. Epub 2009 Dec 11.

30.

Quercetin stimulates Na+/K+/2Cl- cotransport via PTK-dependent mechanisms in human airway epithelium.

Asano J, Niisato N, Nakajima K, Miyazaki H, Yasuda M, Iwasaki Y, Hama T, Dejima K, Hisa Y, Marunaka Y.

Am J Respir Cell Mol Biol. 2009 Dec;41(6):688-95. doi: 10.1165/rcmb.2008-0338OC. Epub 2009 Feb 27.

PMID:
19251944
31.

ALEXA: a microarray design platform for alternative expression analysis.

Griffith M, Tang MJ, Griffith OL, Morin RD, Chan SY, Asano JK, Zeng T, Flibotte S, Ally A, Baross A, Hirst M, Jones SJ, Morin GB, Tai IT, Marra MA.

Nat Methods. 2008 Feb;5(2):118. doi: 10.1038/nmeth0208-118. No abstract available.

PMID:
18235430
32.

Development of glutathione S-transferase-P-negative foci accompanying nuclear factor-erythroid 2-related factor 2 expression during early stage of rat hepatocarcinogenesis.

Fan Y, Shimizu T, Yamada T, Nanashima N, Akita M, Asano J, Tsuchida S.

Cancer Sci. 2008 Mar;99(3):497-501. Epub 2007 Dec 15.

33.

2-Aryl-3,3,3-trifluoro-2-hydroxypropionic acids: a new class of protein tyrosine phosphatase 1B inhibitors.

Adams DR, Abraham A, Asano J, Breslin C, Dick CA, Ixkes U, Johnston BF, Johnston D, Kewnay J, Mackay SP, MacKenzie SJ, McFarlane M, Mitchell L, Spinks D, Takano Y.

Bioorg Med Chem Lett. 2007 Dec 1;17(23):6579-83. Epub 2007 Sep 25.

PMID:
17931864
34.

Assessment of algorithms for high throughput detection of genomic copy number variation in oligonucleotide microarray data.

Baross A, Delaney AD, Li HI, Nayar T, Flibotte S, Qian H, Chan SY, Asano J, Ally A, Cao M, Birch P, Brown-John M, Fernandes N, Go A, Kennedy G, Langlois S, Eydoux P, Friedman JM, Marra MA.

BMC Bioinformatics. 2007 Oct 2;8:368.

35.

Therapy with bortezomib plus dexamethasone induces osteoblast activation in responsive patients with multiple myeloma.

Ozaki S, Tanaka O, Fujii S, Shigekiyo Y, Miki H, Choraku M, Kagawa K, Asano J, Takeuchi K, Kitazoe K, Hashimoto T, Abe M, Matsumoto T.

Int J Hematol. 2007 Aug;86(2):180-5.

PMID:
17875535
36.

LongSAGE profiling of nine human embryonic stem cell lines.

Hirst M, Delaney A, Rogers SA, Schnerch A, Persaud DR, O'Connor MD, Zeng T, Moksa M, Fichter K, Mah D, Go A, Morin RD, Baross A, Zhao Y, Khattra J, Prabhu AL, Pandoh P, McDonald H, Asano J, Dhalla N, Ma K, Lee S, Ally A, Chahal N, Menzies S, Siddiqui A, Holt R, Jones S, Gerhard DS, Thomson JA, Eaves CJ, Marra MA.

Genome Biol. 2007;8(6):R113.

37.
38.

A physical map of the highly heterozygous Populus genome: integration with the genome sequence and genetic map and analysis of haplotype variation.

Kelleher CT, Chiu R, Shin H, Bosdet IE, Krzywinski MI, Fjell CD, Wilkin J, Yin T, DiFazio SP, Ali J, Asano JK, Chan S, Cloutier A, Girn N, Leach S, Lee D, Mathewson CA, Olson T, O'connor K, Prabhu AL, Smailus DE, Stott JM, Tsai M, Wye NH, Yang GS, Zhuang J, Holt RA, Putnam NH, Vrebalov J, Giovannoni JJ, Grimwood J, Schmutz J, Rokhsar D, Jones SJ, Marra MA, Tuskan GA, Bohlmann J, Ellis BE, Ritland K, Douglas CJ, Schein JE.

Plant J. 2007 Jun;50(6):1063-78. Epub 2007 May 3.

39.

A modified polymerase chain reaction-long serial analysis of gene expression protocol identifies novel transcripts in human CD34+ bone marrow cells.

Zhao Y, Raouf A, Kent D, Khattra J, Delaney A, Schnerch A, Asano J, McDonald H, Chan C, Jones S, Marra MA, Eaves CJ.

Stem Cells. 2007 Jul;25(7):1681-9. Epub 2007 Apr 5.

40.

Large-scale production of SAGE libraries from microdissected tissues, flow-sorted cells, and cell lines.

Khattra J, Delaney AD, Zhao Y, Siddiqui A, Asano J, McDonald H, Pandoh P, Dhalla N, Prabhu AL, Ma K, Lee S, Ally A, Tam A, Sa D, Rogers S, Charest D, Stott J, Zuyderduyn S, Varhol R, Eaves C, Jones S, Holt R, Hirst M, Hoodless PA, Marra MA.

Genome Res. 2007 Jan;17(1):108-16. Epub 2006 Nov 29.

41.

Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation.

Friedman JM, Baross A, Delaney AD, Ally A, Arbour L, Armstrong L, Asano J, Bailey DK, Barber S, Birch P, Brown-John M, Cao M, Chan S, Charest DL, Farnoud N, Fernandes N, Flibotte S, Go A, Gibson WT, Holt RA, Jones SJ, Kennedy GC, Krzywinski M, Langlois S, Li HI, McGillivray BC, Nayar T, Pugh TJ, Rajcan-Separovic E, Schein JE, Schnerch A, Siddiqui A, Van Allen MI, Wilson G, Yong SL, Zahir F, Eydoux P, Marra MA.

Am J Hum Genet. 2006 Sep;79(3):500-13. Epub 2006 Jul 25. Erratum in: Am J Hum Genet. 2006 Dec;79(6):1135. Armstrong, Linlea [added].

42.

Different susceptibility to peroxisome proliferator-induced hepatocarcinogenesis in rats with polymorphic glutathione transferase genes.

Kudo T, Asano J, Shimizu T, Nanashima N, Fan Y, Akita M, Ookawa K, Hayakari M, Yokoyama Y, Suto K, Tsuchida S.

Cancer Sci. 2006 Aug;97(8):703-9. Epub 2006 Jun 23.

43.

A case of angiosarcoma of the nasal cavity successfully treated with recombinant interleukin-2.

Fukushima K, Dejima K, Koike S, Tei G, Asano J, Ueda M, Hyuga M, Oshima W.

Otolaryngol Head Neck Surg. 2006 May;134(5):886-7. No abstract available.

PMID:
16647554
44.

A mouse atlas of gene expression: large-scale digital gene-expression profiles from precisely defined developing C57BL/6J mouse tissues and cells.

Siddiqui AS, Khattra J, Delaney AD, Zhao Y, Astell C, Asano J, Babakaiff R, Barber S, Beland J, Bohacec S, Brown-John M, Chand S, Charest D, Charters AM, Cullum R, Dhalla N, Featherstone R, Gerhard DS, Hoffman B, Holt RA, Hou J, Kuo BY, Lee LL, Lee S, Leung D, Ma K, Matsuo C, Mayo M, McDonald H, Prabhu AL, Pandoh P, Riggins GJ, de Algara TR, Rupert JL, Smailus D, Stott J, Tsai M, Varhol R, Vrljicak P, Wong D, Wu MK, Xie YY, Yang G, Zhang I, Hirst M, Jones SJ, Helgason CD, Simpson EM, Hoodless PA, Marra MA.

Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18485-90. Epub 2005 Dec 13.

45.

Nuclear localization of STAT5A modified with O-linked N-acetylglucosamine and early involution in the mammary gland of Hirosaki hairless rat.

Nanashima N, Asano J, Hayakari M, Nakamura T, Nakano H, Yamada T, Shimizu T, Akita M, Fan Y, Tsuchida S.

J Biol Chem. 2005 Dec 30;280(52):43010-6. Epub 2005 Oct 14.

46.
47.

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2.

Oshima T, Abe M, Asano J, Hara T, Kitazoe K, Sekimoto E, Tanaka Y, Shibata H, Hashimoto T, Ozaki S, Kido S, Inoue D, Matsumoto T.

Blood. 2005 Nov 1;106(9):3160-5. Epub 2005 Jul 19.

48.

Design, synthesis, and AMPA receptor antagonistic activity of a novel 6-nitro-3-oxoquinoxaline-2-carboxylic acid with a substituted phenyl group at the 7 position.

Takano Y, Shiga F, Asano J, Ando N, Uchiki H, Fukuchi K, Anraku T.

Bioorg Med Chem. 2005 Oct 15;13(20):5841-63.

PMID:
15993606
49.

[Holistic medicine for treatment of rheumatoid arthritis].

Kato K, Otake T, Asano J, Nishino J, Yoshida S.

Nihon Rinsho. 2005 Jan;63 Suppl 1:641-3. Review. Japanese. No abstract available.

PMID:
15799434

Supplemental Content

Support Center